AUDENTES THERAPEUTICS INC - COM (BOLD)

CUSIP: 05070R104

Q2 2019 13F Holders as of 30 Jun 2019

Type / Class
Equity / COM
Total 13F shares
44,668,919
Share change
+2,492,715
Total reported value
$1,691,004,753
Put/Call ratio
18%
Price per share
$37.86
Number of holders
145
Value change
+$93,116,243
Number of buys
91
Number of sells
52

Quarterly Holders Quick Answers

What is CUSIP 05070R104?
CUSIP 05070R104 identifies BOLD - AUDENTES THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of AUDENTES THERAPEUTICS INC - COM (BOLD) as of Q2 2019

As of 30 Jun 2019, AUDENTES THERAPEUTICS INC - COM (BOLD) was held by 145 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 44,668,919 shares. The largest 10 holders included BlackRock Inc., Partner Fund Management, L.P., Redmile Group, LLC, WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, GREAT POINT PARTNERS LLC, STATE STREET CORP, GILDER GAGNON HOWE & CO LLC, ORBIMED ADVISORS LLC, and FMR LLC. This page lists 145 institutional shareholders reporting positions in this security for the Q2 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.